Elite Pharmaceuticals Inc (ELTP)

[imanjen13]

Update of the trademark dispute between Pyros Vigpoder application and Upsher Smith whose Vigabatrin generic is trademarked as Vigadrone.

Pyros published its trademark application in September and on 10/17/23 Upsher Smith made a request for an extension of time to file an opposition to the application apparently based upon the similarity of the names. I can find no follow up to indicate that Upsher actually decided to oppose the Pyros trademark designation.
I intend to email the attorney for Pyros, Cheryl Clarkin from the firm of Adler Pollock in Providence RI after the MLK holiday to see if the time to oppose has expired.

For newcomers it should be noted that Elite developed the Pyros generic and then sold it to Pyros with an agreement that Elite would be their sole manufacturer. This drug, used primarily for children with epilepsy, is highly toxic and requires REMs treatment to warn users of the many side effects. This along with the trademark dispute has caused a delay of the pyros launch.

The Vigabatrin drug is very expensive and once launched, I expect the manufacturing costs to be an additional source of revenue for Elite.

Thanks to the King for bringing this development to the Boards attention.